Mettler-Toledo International Inc. (NYSE:MTD) Stock Holdings Decreased by DORCHESTER WEALTH MANAGEMENT Co

DORCHESTER WEALTH MANAGEMENT Co cut its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 4.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,065 shares of the medical instruments supplier’s stock after selling 107 shares during the quarter. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Mettler-Toledo International were worth $3,097,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. PineStone Asset Management Inc. increased its holdings in Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after buying an additional 145,453 shares during the period. Capital International Investors increased its stake in Mettler-Toledo International by 15.1% during the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after purchasing an additional 141,431 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after acquiring an additional 89,922 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Mettler-Toledo International by 88.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock valued at $163,290,000 after buying an additional 57,509 shares in the last quarter. Finally, TD Asset Management Inc lifted its holdings in Mettler-Toledo International by 53.1% during the 1st quarter. TD Asset Management Inc now owns 154,381 shares of the medical instruments supplier’s stock valued at $205,526,000 after purchasing an additional 53,561 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MTD has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. lifted their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. The Goldman Sachs Group upped their price target on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a report on Tuesday, July 9th. StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price objective for the company. Finally, Evercore ISI upped their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,363.75.

Insider Activity at Mettler-Toledo International

In other news, insider Christian Magloth sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Christian Magloth sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shawn Vadala sold 250 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD traded down $7.00 on Thursday, hitting $1,313.35. The company’s stock had a trading volume of 7,854 shares, compared to its average volume of 132,321. The company has a 50-day simple moving average of $1,421.35 and a 200 day simple moving average of $1,394.57. Mettler-Toledo International Inc. has a 1 year low of $928.49 and a 1 year high of $1,546.93. The company has a market capitalization of $28.05 billion, a PE ratio of 37.03, a PEG ratio of 4.24 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating analysts’ consensus estimates of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The company had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. During the same quarter in the prior year, the company earned $10.19 earnings per share. The firm’s revenue for the quarter was down 3.6% on a year-over-year basis. On average, equities research analysts expect that Mettler-Toledo International Inc. will post 40.35 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.